Clinical Trial Update: anti10a Levels in Women Treated With LMWH in the Postpartum Period [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating anti-10a levels in women treated with low molecular weight heparin during the postpartum period for venous thromboembolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• LMWH (low molecular weight heparin)
• anti10a (anti-factor Xa activity)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Venous Thromboembolism | Phase 4 | Status: COMPLETED